SYSCHEM (INDIA)
Back to Balance Sheet
|
SYSCHEM (INDIA) Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹50 Cr | ₹1.12 Cr | ₹1.44 Cr | ₹0.73 Cr | ₹0.75 Cr |
What is the latest Contingent Liabilities ratio of SYSCHEM (INDIA) ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹50 Cr |
| Mar2024 | ₹1.12 Cr |
| Mar2023 | ₹1.44 Cr |
| Mar2022 | ₹0.73 Cr |
| Mar2021 | ₹0.75 Cr |
How is Contingent Liabilities of SYSCHEM (INDIA) Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹50 Cr | 4,385.17 | |
| Mar2024 | ₹1.12 Cr | -22.29 | |
| Mar2023 | ₹1.44 Cr | 98.62 | |
| Mar2022 | ₹0.73 Cr | -3.07 | |
| Mar2021 | ₹0.75 Cr | - | |
Compare Contingent Liabilities of peers of SYSCHEM (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYSCHEM (INDIA) | ₹159.6 Cr | 0.6% | -1% | -44.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,196.0 Cr | 1.8% | -1.7% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹250,390.0 Cr | 2.6% | 9.8% | 54.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,967.0 Cr | 2.4% | -0.5% | 36% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | 1.8% | -3.7% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,329.0 Cr | 4.5% | 1.8% | -10% | Stock Analytics | |
SYSCHEM (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYSCHEM (INDIA) | 0.6% |
-1% |
-44.9% |
| SENSEX | 0.1% |
-2.7% |
-8.6% |
You may also like the below Video Courses